MZ
Michael Zile
Medical University of South Carolina
Research areas: Medicine · Cardiology and Cardiovascular Medicine · Heart Failure Treatment and Management · Cardiovascular Function and Risk Factors · Cardiac Fibrosis and Remodeling
0000-0001-7076-221X
Employment
-
Medical University of South Carolina Professor
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (429)
- Modeling Individual Patient Outcomes After Interatrial Shunt Treatment in Heart Failure With Reduced and Preserved Ejection Fraction: The RELIEVE-HF Trial Save
- Changes in Pulmonary Artery Pressure Following Initiation of Guideline-Directed Medical Therapies in Patients With Heart Failure: Insights From GUIDE-HF Save
- Heart rate and atrial fibrillation/flutter in HFmrEF/HFpEF: a participant-level analysis across five randomized clinical trials Save
- Visceral adiposity assessment to enhance risk stratification in heart failure with preserved ejection fraction Save
- Normal abundance of immune cells in left ventricular myocardium from patients with heart failure and preserved ejection fraction Save
- Estimating the Placebo Effect on Patient-Reported Outcomes in Sham-Controlled Device Trials: Insights From REDUCE LAP-HF II Save
- Response by Zile et al to Letter Regarding Article, “Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity” Save
- Incidence of Atrial Fibrillation in Patients with an Insertable Cardiac Monitor and Symptomatic Heart Failure Save
- Relationship Between Remote, Ambulatory Pulmonary Artery Pressures, and All-Cause Mortality in Patients With Chronic Heart Failure Save
- Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity Save
- Impact of Multimorbidity on Mortality in Heart Failure With Mildly Reduced and Preserved Ejection Fraction Save
- Interatrial Shunt Treatment for Heart Failure: The Randomized RELIEVE-HF Trial Save
- Personalized Intervention Strategy Based on a Risk Score Generated From Subcutaneous Insertable Cardiac Monitor: Results From Phase 1 of ALLEVIATE‐HF Save
- Clinical Characteristics and Outcomes in Patients With Heart Failure: Are There Thresholds and Inflection Points in Left Ventricular Ejection Fraction and Thresholds Justifying a Clinical Classification? Save
- Left Ventricular Gene Expression in Heart Failure With Preserved Ejection Fraction—Profibrotic and Proinflammatory Pathways and Genes Save
- Importance of cystatin C in estimating glomerular filtration rate: the PARADIGM-HF trial Save
- Urinary cGMP (Cyclic Guanosine Monophosphate)/BNP (B-Type Natriuretic Peptide) Ratio, Sacubitril/Valsartan, and Outcomes in Heart Failure With Reduced Ejection Fraction: An Analysis of the PARADIGM-HF Trial Save
- The GUIDE-HF trial of pulmonary artery pressure monitoring in heart failure: impact of the COVID-19 pandemic Save
- Diastolic Dysfunction With Preserved Ejection Fraction After the Fontan Procedure Save
- Non-invasive MR imaging of human brain lymphatic networks with connections to cervical lymph nodes Save